Admission blood glucose level as a risk factor in patients with and without diabetes mellitus after acute myocardial infarction
Authors:
R. Adámková 1; S. Janoušek 1; A. Tomášek 1; J. Tůmová 2; Z. Čermáková 2; J. Kaňovský 1; J. Špinar 1
Authors‘ workplace:
Interní kardiologická klinika
LF MU a FN Brno, pracoviště Bohunice
1; Oddělení klinické biochemie
LF MU a FN Brno, pracoviště Bohunice
2
Published in:
Kardiol Rev Int Med 2007, 9(2): 99-103
Category:
Editorial
Overview
We advanced six-months´ analysis of admission blood glucose level at 870 patients with acute myocardial infarction in dependence on existence of diagnosis diabetes mellitus, which were admitted to our coronary care unit in years 2003 and 2004. Elevated admission blood glucose level was found also in 276 (45,6%) non-diabetic patients. We proved higher mortality at these patients, the highest mortality was found in non-diabetic patients with admission blood glucose level 11.1 mmol/l or higher (30,3% vs. 20% mortality in group of diabetic patients). These results support worse clinical progres sof acute myocardial infarction not only at diabetic patients, but in patients with higher admission blood glucose level, too.
Key words:
acute myocardial infarction, admission blood glucose level, prognosis, diabetes mellitus, mortality
Sources
1.Kandel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-2038.
2.Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
3.Hammoud T et al. Léčba koronární nemoci: možnosti u pacientů s diabetes mellitus. JACC-CZ 2001; 1: 31-41.
4.Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9: 259-264.
5.Behar S, Boyko V, Reicher-Reiss H, Goldbourt U. SPRINT Study Group. Ten year survival after acute myocardial infarction: comparison of patiens with and without diabetes: Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J 1997; 133: 290-296.
6.Woodfield SL et al. Angiographyc findings and outcome in diabetic pateints treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996; 28: 1661-1669.
7.Tschöpe D, Bode CH. Impaired glukose tolerance – a new risk factor? Europ Heart J 2004; 25: 1969.
8.Mak KH, Moliterno DJ et al. Influence of diabetes mellitus on clinical outcome in the trombolytic era of acute myocardial infarction. J Am Coll Cardiol 1997; 30: 171-179.
9.O´Sullivan JJ, Conroy RM, Robinson K et al. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758-760.
10.Fava S, Aquilina O, Azzopardi J et al. The prognostic value of blood glucose in diabetic patients with acute myocardial infaction. Diabet Med 1996; 13: 80-83.
11.Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of asmission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989; 71: 461-466.
12.Mak KH, Mah PK, Tey BH et al. Fasting blood sugar level: a determinant for in-hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 1993; 22: 291-295.
13.Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long.term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-1831.
14.Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocyrdial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
15.Norhammar A, Tennerz A, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-2144.
16.Bartnik M, Malmberg K, Norhammar A et al. Newly detected abnormal glukose tolerance: an important predictor of long-term outcome after myocardial infarction. Europ Heart J 2004; 25: 1990-1997.
17.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
18.Alberti KG, Zimmel PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
19.Vetter NJ, Strange RC, Adams W, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 1: 284-288.
20.Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabeticpatients with myocardial infarction. BMJ 1986; 293: 917-922.
21.Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet 1994; 343: 155-158.
22.Bellodi G, Manicardi V, Malavasi V et al. Hyperglycemiaand prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885-888.
23.Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
24.Heine RH, Dekker JM. Beyond postprandial hyperglycemia: metabolix factors associated with cardiovascular disease. Diabetologia 2002; 45: 461-475.
25.Haffnet SM, Stern MP, Hazuda HP et al. Cardiovasculat tisk factors in confirmed presiabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898.
26.Nomenclature and criteria for diagnosis of ischemie heart disease: report of the Joint International Society and Federation of Cardiology/World Health Orfanization task force on standardization of clinical nomenclature. Circulation 1979; 59: 607-609.
27.Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321.
28.Davi G, Catalano I, Averna M et al. Thromboxane biosynthesis and platelet function in typu II diabetes mellitus. N Engl J Med 1990; 322: 1769-1774.
29.Jain SK, Nagi DK, Slavin BM et al. Insulin therapy in typu 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabet Med 1993; 10: 27-32.
30.Kawano H, Motoyama T, Hirashima O et al. Hyperglycaemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
31.Williams SB, Goldfine AB, Timimi FK et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.
32.Sodi-Pallares D, Testelli MR, Fishleder BL et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction: a preliminary report. Am J Cardiol 1962; 5: 166-181.
33.Malmberg K, Ryden L, Efendic S et al. Ramdomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
34.Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632.
35.Janoušek S, Hlinomaz O. Novinky ze světového kardiologického kongresu v Barceloně. Interv Akut Kardiol 2006; 6: 220-222.
36.Malmberg K, Rydén L, Wedel H et al. Intense metabolit kontrol by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on motality and morbidity. Eur Heart J 2005; 26: 650-661.
37.Balkau B, Bertrais S, Ducimetiere P, Eschwege E. Is there a glycemie threshold for mortality risk? Diabetes Care 1999; 22: 696-699.
38.Tenerz A, Lonnberg I, Berne C et al. Myocardial infarction and prevalence of diabetes mellitus: is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001; 22: 1102-1110.
39.Bolk J, van der Ploeg TJ, Cornel JH et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001; 79: 207-214.
40.King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-177.
41.Mooy JM, Grootenhuis PA, de Vries H et al. Prevalence and determinants of glucose intolerance in a Caucasian population: the Hoorn Study. Diabetes Care 1995; 18: 1270-1273.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2007 Issue 2
Most read in this issue
- Dual anti-aggregation therapy in the prevention cerebral infarction
- Acute coronary syndromes – therapy of hyperglycaemia
- Myocardial infarction in elderly pacients
- Acute myocardial infarction in renal insufficiency II: Contrast induced nephropathy, modern continuous elimination methods, importance of troponin evaluation